American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

Gilead Sciences Inc

GILD Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

GILD historical prices

$GILD is featured in our Rob Bresnahan and Shelley Moore Capito strategies.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of GILD by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Sale $1,001 - $15,000 Aug 10, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 20, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Jul 07, 2026
Ro Khanna House / D Sale $15,001 - $50,000 Jun 16, 2026
Ro Khanna House / D Purchase $15,001 - $50,000 May 15, 2026
Jared Moskowitz House / D Purchase $1,001 - $15,000 May 06, 2026
Jared Moskowitz House / D Purchase $1,001 - $15,000 May 06, 2026
Ro Khanna House / D Sale $15,001 - $50,000 Apr 13, 2026
Alan Armstrong Senate / R Purchase $1,001 - $15,000 Mar 27, 2026
Ro Khanna House / D Purchase $15,001 - $50,000 Jan 29, 2026
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jan 27, 2026
Val T. Hoyle House / D Sale $1,001 - $15,000 Sep 23, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Jun 06, 2025
Josh Gottheimer House / D Sale $1,001 - $15,000 May 14, 2025
Jefferson Shreve House / R Sale $15,001 - $50,000 May 12, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 May 05, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 May 05, 2025
John Boozman Senate / R Sale (Full) $1,001 - $15,000 Apr 16, 2025
Jefferson Shreve House / R Purchase $15,001 - $50,000 Mar 31, 2025
Carol D. Miller House / R Purchase $1,001 - $15,000 Mar 10, 2025
Josh Gottheimer House / D Purchase $1,001 - $15,000 Mar 07, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Dec 24, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 15, 2024
Val T. Hoyle House / D Purchase $1,001 - $15,000 Oct 29, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 02, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 May 29, 2024
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 May 10, 2024
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 May 10, 2024
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 May 10, 2024
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 May 08, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Apr 26, 2024
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Apr 05, 2024
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Apr 03, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 25, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Feb 13, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 05, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 03, 2023
HON. GREG STANTON House / D Sale $1,001 - $15,000 Oct 24, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Oct 02, 2023
HON. GREG STANTON House / D Purchase $1,001 - $15,000 Sep 26, 2023
Daniel S. Goldman House / D Sale $15,001 - $50,000 Jul 12, 2023
Zoe Lofgren House / D Sale $1,001 - $15,000 May 25, 2023
Daniel S. Goldman House / D Purchase $15,001 - $50,000 Mar 06, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 29, 2022
Zoe Lofgren House / D Purchase $1,001 - $15,000 Sep 09, 2022
Ro Khanna House / D Sale $1,001 - $15,000 Aug 01, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 May 10, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 21, 2022
Ro Khanna House / D Sale $1,001 - $15,000 N/A
GILD Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
GILD Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
GILD Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in GILD holdings by institutional investors

Insider Trading

Quarterly net insider trading by GILD's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $1,590,000 Jul 20, 2026 Issue: Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues Medicare/Medicaid
  • $3,190,000 Apr 20, 2026 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code
  • $1,700,000 Jan 20, 2026 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code
  • $2,780,000 Oct 20, 2025 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code
  • $1,700,000 Jul 21, 2025 Issue: Health Issues Trade (domestic/foreign) Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code
  • $1,662,000 Apr 21, 2025 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code
  • $2,440,000 Jan 21, 2025 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code
  • $2,050,000 Oct 21, 2024 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
  • $1,530,000 Jul 22, 2024 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
  • $1,680,000 Jan 23, 2024 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
  • $2,390,000 Oct 20, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
  • $1,440,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
  • $1,490,000 Apr 14, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
  • $2,520,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
  • $1,372,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
  • $2,620,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
  • $1,980,000 Jan 19, 2022 Issue: None
  • $2,290,000 Oct 20, 2021 Issue: None
  • $1,380,000 Jul 20, 2021 Issue: None
  • $2,530,000 Apr 20, 2021 Issue: None
  • $1,510,000 Jan 20, 2021 Issue: None
  • $1,810,000 Oct 20, 2020 Issue: None
  • $1,260,000 Jul 20, 2020 Issue: None
  • $2,450,000 Apr 20, 2020 Issue: None
  • $1,300,000 Jan 21, 2020 Issue: None
  • $1,480,000 Oct 21, 2019 Issue: Budget/Appropriations Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)
  • $1,080,000 Jul 22, 2019 Issue: Indian/Native American Affairs Budget/Appropriations Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $1,860,000 Apr 23, 2019 Issue: Indian/Native American Affairs Budget/Appropriations Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Veterans Copyright/Patent/Trademark Health Issues
  • $700,000 Jan 22, 2019 Issue: Medicare/Medicaid Defense Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Veterans Budget/Appropriations Indian/Native American Affairs Taxation/Internal Revenue Code
  • $680,000 Oct 22, 2018 Issue: Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Indian/Native American Affairs Budget/Appropriations
  • $800,000 Jul 20, 2018 Issue: Indian/Native American Affairs Budget/Appropriations Medicare/Medicaid Foreign Relations Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Veterans Trade (domestic/foreign)
  • $810,000 Apr 20, 2018 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Veterans Foreign Relations Indian/Native American Affairs Budget/Appropriations Taxation/Internal Revenue Code
  • $900,000 Jan 22, 2018 Issue: Indian/Native American Affairs Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Veterans Foreign Relations
  • $810,000 Oct 20, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Veterans Copyright/Patent/Trademark Foreign Relations Trade (domestic/foreign) Taxation/Internal Revenue Code Pharmacy Indian/Native American Affairs
  • $790,000 Jul 20, 2017 Issue: Pharmacy Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Veterans Trade (domestic/foreign) Indian/Native American Affairs Foreign Relations Taxation/Internal Revenue Code
  • $1,050,000 Apr 20, 2017 Issue: Law Enforcement/Crime/Criminal Justice Pharmacy Medicare/Medicaid Foreign Relations Health Issues Copyright/Patent/Trademark Indian/Native American Affairs Veterans Trade (domestic/foreign) Taxation/Internal Revenue Code Budget/Appropriations
  • $960,000 Jan 19, 2017 Issue: Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Budget/Appropriations Foreign Relations Trade (domestic/foreign) Law Enforcement/Crime/Criminal Justice Pharmacy
  • $780,000 Oct 20, 2016 Issue: Law Enforcement/Crime/Criminal Justice Pharmacy Medicare/Medicaid Foreign Relations Veterans Health Issues Copyright/Patent/Trademark Budget/Appropriations Trade (domestic/foreign) Defense
  • $760,000 Jul 19, 2016 Issue: Medicare/Medicaid Foreign Relations Health Issues Pharmacy Trade (domestic/foreign) Veterans Defense Budget/Appropriations Copyright/Patent/Trademark
  • $980,000 Apr 18, 2016 Issue: Science/Technology Pharmacy Medicare/Medicaid Foreign Relations Veterans Health Issues Trade (domestic/foreign) Defense Budget/Appropriations Copyright/Patent/Trademark
  • $890,000 Jan 20, 2016 Issue: Science/Technology Pharmacy Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark Veterans Foreign Relations Defense Budget/Appropriations
  • $700,000 Oct 19, 2015 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Defense Trade (domestic/foreign) Foreign Relations Budget/Appropriations Copyright/Patent/Trademark Science/Technology
  • $550,000 Jul 20, 2015 Issue: Science/Technology Pharmacy Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Defense Foreign Relations Budget/Appropriations Trade (domestic/foreign)
  • $800,000 Apr 21, 2015 Issue: Medicare/Medicaid Health Issues Veterans Trade (domestic/foreign) Defense Copyright/Patent/Trademark
  • $620,000 Jan 19, 2015 Issue: Medicare/Medicaid Health Issues Veterans Trade (domestic/foreign) Defense Copyright/Patent/Trademark
  • $640,000 Oct 17, 2014 Issue: Medicare/Medicaid Health Issues Veterans Trade (domestic/foreign) Copyright/Patent/Trademark
  • $820,000 Jul 15, 2014 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $810,000 Apr 18, 2014 Issue: Medicare/Medicaid Veterans Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
  • $550,000 Jan 21, 2014 Issue: Health Issues Copyright/Patent/Trademark Veterans Medicare/Medicaid
  • $540,000 Oct 21, 2013 Issue: Health Issues Copyright/Patent/Trademark Veterans Medicare/Medicaid
  • $623,000 Aug 05, 2013 Issue: Health Issues Copyright/Patent/Trademark
  • $510,000 Jul 19, 2013 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $320,000 Jan 22, 2013 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $370,000 Oct 22, 2012 Issue: Health Issues
  • $340,000 Jul 20, 2012 Issue: Health Issues
  • $560,000 Apr 20, 2012 Issue: Health Issues
  • $400,000 Jan 20, 2012 Issue: Health Issues
  • $370,000 Oct 20, 2011 Issue: Health Issues
  • $390,000 Jul 20, 2011 Issue: Health Issues
  • $500,000 Apr 20, 2011 Issue: Health Issues
  • $340,000 Jan 20, 2011 Issue: Health Issues
  • $350,000 Oct 20, 2010 Issue: Health Issues
  • $350,000 Jul 20, 2010 Issue: Health Issues
  • $480,000 Apr 20, 2010 Issue: Health Issues
  • $370,000 Jan 20, 2010 Issue: Health Issues
  • $350,000 Oct 20, 2009 Issue: Health Issues
  • $290,000 Jul 20, 2009 Issue: Health Issues
  • $270,000 Apr 20, 2009 Issue: Health Issues
  • $240,000 Jan 09, 2009 Issue: Health Issues
  • $240,000 Oct 28, 2008 Issue: Health Issues
  • $260,000 Oct 28, 2008 Issue: Health Issues
  • $260,000 Jun 25, 2008 Issue: Health Issues
  • $280,000 Feb 14, 2008 Issue: Health Issues
  • $380,000 Aug 14, 2007 Issue: Health Issues
  • $355,000 Feb 13, 2007 Issue: Health Issues
  • $455,000 Aug 14, 2006 Issue: Health Issues
  • $180,000 Apr 06, 2006 Issue: Health Issues
  • $60,000 Aug 24, 2005 Issue: Medical/Disease Research/Clinical Labs
  • $140,000 Aug 22, 2005 Issue: Health Issues
  • $20,000 Aug 15, 2005 Issue: Trade (domestic/foreign)
  • $40,000 Feb 09, 2005 Issue: None
  • $40,000 Sep 08, 2004 Issue: Health Issues
  • $100,000 Apr 12, 2004 Issue: Health Issues Pharmacy
  • $100,000 Aug 15, 2003 Issue: Health Issues Pharmacy
  • $100,000 Mar 03, 2003 Issue: Health Issues Pharmacy
  • $100,000 Aug 14, 2002 Issue: Health Issues Pharmacy
  • $60,000 Feb 14, 2002 Issue: Health Issues Pharmacy
Revolving Door

Former government officials who have lobbied for GILD

119 former government officials from 71 congressional offices at 24 lobbying firms have lobbied for GILD, most recently Jul 21, 2026.

  • Raissa Downs Senate Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte. Formerly HELP Cmte. · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Jennifer Young Congress Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance Formerly Cmte. on Finance · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Steny H. Hoyer
    Elizabeth Murray House Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham Formerly with Steny H. Hoyer · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Jim DeMint
    Charlotte Ivancic Senate Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner Formerly with Jim DeMint · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Tom Harkin
    Pamela Smith Senate Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun Formerly with Tom Harkin · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Emily Murry House Staff Dir., Sub. Cmte. on Health, W&M Cmte; Sr. Policy Advisor, Majority Leader McCarthy; Policy Advisor, Majority Whip McCarthy; Professional Staff, Republican Study Cmte.; Leg. Aid, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price Formerly Ken Calvert · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Kyrsten Sinema
    Margaret Joseph Senate CoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte. Formerly with Kyrsten Sinema · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Peter Fise Congress Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform Formerly Cmte on Finance · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
See all 119 on the Revolving Door dashboard
Corporate Lobbying

GILD Estimated quarterly lobbying spending

Revenue Breakdown

GILD Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
GILD Income Statement
GILD Balance Sheet
GILD Cash Flow
U.S. Patents

New GILD patent grants

  • Patent Title: Blister pack Aug. 11, 2026
  • Patent Title: Pharmaceutical package Jun. 23, 2026
  • Patent Title: Blister pack Mar. 17, 2026
  • Patent Title: Blister pack Sep. 23, 2025
  • Patent Title: Blister pack Aug. 05, 2025
  • Patent Title: Pouch Jul. 29, 2025
  • Patent Title: Carton Jun. 17, 2025
  • Patent Title: Blister pack May. 20, 2025
  • Patent Title: Blister pack Mar. 04, 2025
  • Patent Title: Blister pack Feb. 25, 2025
  • Patent Title: Blister pack May. 09, 2023
  • Patent Title: Blister pack May. 09, 2023
  • Patent Title: Blister pack packaging blank Feb. 28, 2023
  • Patent Title: Blister pack Dec. 27, 2022
  • Patent Title: Blister pack Dec. 27, 2022
  • Patent Title: Blister pack Aug. 23, 2022
  • Patent Title: Blister pack Aug. 16, 2022
  • Patent Title: Pharmaceutical package Jul. 26, 2022
  • Patent Title: Pharmaceutical package Jul. 26, 2022
  • Patent Title: Pharmaceutical package Jun. 21, 2022
  • Patent Title: Apoptosis signal-regulating kinase inhibitors Aug. 31, 2021
  • Patent Title: Apoptosis signal-regulating kinase inhibitors Aug. 11, 2020
  • Patent Title: 2-(n-pyrazolo)adenosines with application as adenosine a Apr. 16, 2019
  • Patent Title: Macrocyclic inhibitors of flaviviridae viruses Apr. 02, 2019
  • Patent Title: Process for preparing an a2a-adenosine receptor agonist and its polymorphs Mar. 19, 2019
  • Patent Title: 1′-substituted carba-nucleoside analogs for antiviral treatment Mar. 27, 2018
  • Patent Title: Method for treating a pulmonary hypertension condition Oct. 25, 2016
  • Patent Title: (n-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide Oct. 18, 2016
  • Patent Title: Therapeutic compounds Oct. 11, 2016
  • Patent Title: Methods of treating patients co-infected with hiv and tuberculosis Oct. 11, 2016
  • Patent Title: Substituted pyrido[1′,2′:4,5]pyrazino[1,2-a]azepines for treating viral infections Oct. 04, 2016
  • Patent Title: Benzimidazole derivatives as bromodomain inhibitors Oct. 04, 2016
  • Patent Title: Compositions and methods for combination antiviral therapy Oct. 04, 2016
  • Patent Title: Antiviral compounds Oct. 04, 2016
  • Patent Title: Modulators of toll-like receptors Sep. 27, 2016
  • Patent Title: Methods for treating hcv Sep. 27, 2016
  • Patent Title: Synthesis of an antiviral compound Sep. 13, 2016
  • Patent Title: Methods and intermediates for preparing pharmaceutical agents Aug. 30, 2016
  • Patent Title: Polycyclic-carbamoylpyridone compounds and their pharmaceutical use Aug. 23, 2016
  • Patent Title: Fused heterocyclic compounds as ion channel modulators Aug. 16, 2016
  • Patent Title: Fused heterocyclic compounds as ion channel modulators Aug. 02, 2016
  • Patent Title: Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections Jul. 12, 2016
  • Patent Title: Salts of hiv inhibitor compounds Jul. 05, 2016
  • Patent Title: Substituted pyrrolidines as syk inhibitors Jun. 28, 2016
  • Patent Title: 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating aids Jun. 28, 2016
  • Patent Title: Fused heterocyclic compounds as ion channel modulators Jun. 21, 2016
  • Patent Title: Hcv genotype 6 replicons May. 31, 2016
  • Patent Title: Methods for preparing anti-viral nucleotide analogs May. 24, 2016
  • Patent Title: Methods and intermediates for preparing pharmaceutical agents May. 24, 2016
  • Patent Title: Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections May. 24, 2016
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to GILD from public contracts

GILD News

Recent insights relating to GILD

CNBC Recommendations

Recent picks made for GILD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GILD

GILD Analyst Ratings

GILD Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
GILD Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $GILD stock a Buy, Sell, or Hold?

  • What is the price target for $GILD stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

GILD Top Shareholders
Shareholder
Shares Held
GILD Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $GILD stock?

  • Who owns the most shares of $GILD stock?

  • What funds own $GILD stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

GILD Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view GILD Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About GILD

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

  • Address Foster City, CA
  • Market Cap 187.7 billion
  • Employees 17,000
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Gilead Sciences Inc (GILD) Historical Stock Prices

Gilead Sciences Inc (GILD) closed at $151.37 on September 23, 2026. Over the past year its adjusted close ranged from $108.50 to $153.91. Daily prices go back to January 2, 2014, 3,200 trading days in all.

  • 1 month+3.16%
  • 3 months+20.94%
  • Year to date+24.84%
  • 1 year+34.83%
  • 3 years+120.54%
  • 5 years+152.49%
  • Max+193.32%
See every congressional and insider trade on the GILD price chart

Quiver Premium charts GILD's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 153.60 154.20 150.06 151.37 151.37 6,191,894
Sep 22, 2026 150.65 153.28 148.65 152.67 152.67 5,082,660
Sep 21, 2026 150.11 152.09 148.22 150.56 150.56 5,569,448
Sep 18, 2026 150.56 153.23 149.57 150.11 150.11 16,421,966
Sep 17, 2026 148.78 151.04 146.89 150.89 150.89 7,843,647
Sep 16, 2026 146.58 149.30 146.12 147.68 147.68 5,188,250
Sep 15, 2026$0.82 dividend 144.00 146.35 142.94 146.30 146.30 4,536,022
Sep 14, 2026 144.26 146.75 143.71 146.41 146.41 4,920,293
Sep 11, 2026 145.24 145.99 143.50 143.72 143.72 4,202,446
Sep 10, 2026 145.07 145.91 143.67 144.81 144.81 6,019,851
Sep 9, 2026 145.46 147.68 145.00 145.65 145.65 4,583,213
Sep 8, 2026 146.98 148.65 145.45 146.64 146.64 6,080,502
Sep 4, 2026 149.23 151.19 149.23 151.00 151.00 6,181,783
Sep 3, 2026 150.67 151.48 148.41 151.22 151.22 4,498,099
Sep 2, 2026 150.00 152.55 148.83 149.61 149.61 4,923,290
Sep 1, 2026 148.52 149.96 146.91 149.92 149.92 4,870,766
Aug 31, 2026 144.23 147.22 143.18 146.34 146.34 6,594,694
Aug 28, 2026 149.47 149.47 144.88 145.68 145.68 3,946,913
Aug 27, 2026 147.30 149.10 146.01 148.86 148.86 5,014,794
Aug 26, 2026 148.00 149.62 147.00 148.09 148.09 5,259,811
Aug 25, 2026 146.60 148.94 145.58 148.77 148.77 4,630,523
Aug 24, 2026 145.93 146.84 144.59 146.74 146.74 6,183,604
Aug 21, 2026 144.52 147.91 143.50 146.12 146.12 5,384,711
Aug 20, 2026 146.69 146.82 143.19 143.44 143.44 7,167,579
Aug 19, 2026 145.10 148.97 144.30 147.60 147.60 6,738,817
Aug 18, 2026 140.00 143.89 139.54 143.44 143.44 5,758,845
Aug 17, 2026 138.36 139.49 136.63 138.92 138.92 3,940,375
Aug 14, 2026 136.81 138.43 135.91 138.36 138.36 3,407,825
Aug 13, 2026 136.94 138.30 136.03 138.14 138.14 4,897,034
Aug 12, 2026 133.99 137.12 133.29 135.87 135.87 5,683,968
Aug 11, 2026 132.68 136.85 132.01 135.77 135.77 5,493,691
Aug 10, 2026 131.61 134.32 131.61 133.06 133.06 6,833,770
Aug 7, 2026 132.10 134.09 130.59 133.21 133.21 8,202,062
Aug 6, 2026 133.99 134.48 129.02 130.86 130.86 9,235,052
Aug 5, 2026 136.00 137.80 129.60 131.76 131.76 11,383,394
Aug 4, 2026 131.15 135.57 129.54 135.25 135.25 10,091,364
Aug 3, 2026 131.09 131.50 129.04 131.15 131.15 7,523,916
Jul 31, 2026 130.23 130.88 128.76 130.21 130.21 6,531,645
Jul 30, 2026 130.02 131.39 128.28 131.28 131.28 6,726,143
Jul 29, 2026 134.41 134.64 132.56 132.73 132.73 7,766,370
Jul 28, 2026 133.11 136.26 132.63 134.32 134.32 6,947,167
Jul 27, 2026 131.00 133.06 129.43 130.52 130.52 4,953,801
Jul 24, 2026 130.93 131.65 129.04 129.31 129.31 5,529,741
Jul 23, 2026 129.22 131.07 127.61 130.86 130.86 6,299,287
Jul 22, 2026 131.83 132.86 130.23 130.34 130.34 4,757,764
Jul 21, 2026 130.51 132.87 129.13 130.28 130.28 8,371,109
Jul 20, 2026 134.28 135.50 132.91 133.21 133.21 4,103,979
Jul 17, 2026 137.61 140.61 134.09 134.28 134.28 6,903,235
Jul 16, 2026 131.76 136.44 131.31 136.30 136.30 7,926,819
Jul 15, 2026 130.09 132.95 129.41 131.70 131.70 4,467,637
Jul 14, 2026 129.70 131.21 129.42 130.04 130.04 5,255,960
Jul 13, 2026 129.66 131.67 127.94 131.40 131.40 5,131,594
Jul 10, 2026 134.02 134.97 129.26 129.83 129.83 5,935,997
Jul 9, 2026 135.57 136.06 133.27 134.84 134.84 5,839,339
Jul 8, 2026 136.58 137.70 134.00 135.82 135.82 8,454,142
Jul 7, 2026 132.62 136.60 132.00 136.36 136.36 9,177,296
Jul 6, 2026 132.88 132.88 127.88 129.61 129.61 10,729,369
Jul 2, 2026 126.72 131.58 126.46 131.27 131.27 8,088,800
Jul 1, 2026 127.28 127.62 125.12 125.97 125.97 6,654,936
Jun 30, 2026 125.88 127.27 124.19 126.34 126.34 7,409,570
Jun 29, 2026 128.86 128.86 125.49 126.33 126.33 6,897,708
Jun 26, 2026 125.25 128.70 125.00 127.88 127.88 19,908,542
Jun 25, 2026 125.27 126.95 123.67 123.84 123.84 7,250,735
Jun 24, 2026 125.56 127.27 124.78 125.16 125.16 7,409,629
Jun 23, 2026 126.63 126.63 124.44 125.05 125.05 8,462,589
Jun 22, 2026 124.30 125.17 123.00 124.87 124.87 8,126,312
Jun 18, 2026 125.84 126.39 122.43 123.76 123.76 14,348,342
Jun 17, 2026 126.69 128.20 124.11 125.45 125.45 7,726,714
Jun 16, 2026 125.22 128.18 124.14 127.23 127.23 9,381,890
Jun 15, 2026$0.82 dividend 125.29 125.40 122.70 124.30 124.30 6,653,106
Jun 12, 2026 126.13 126.50 124.29 125.59 124.77 5,216,092
Jun 11, 2026 121.79 127.37 121.79 125.87 125.05 8,665,609
Jun 10, 2026 125.64 125.64 121.39 121.48 120.68 10,154,248
Jun 9, 2026 128.80 129.00 123.20 125.50 124.68 8,683,055
Jun 8, 2026 130.07 130.80 127.13 128.10 127.26 9,795,952
Jun 5, 2026 130.09 131.66 128.92 129.16 128.31 15,369,357
Jun 4, 2026 130.57 131.04 128.01 129.18 128.33 13,729,210
Jun 3, 2026 127.59 129.86 127.50 128.99 128.15 6,237,144
Jun 2, 2026 128.99 130.60 127.07 127.57 126.73 8,082,551
Jun 1, 2026 133.99 133.99 130.53 131.10 130.24 6,259,248
May 29, 2026 135.12 137.20 133.54 134.43 133.55 17,510,274
May 28, 2026 133.89 136.51 132.79 136.22 135.33 5,611,605
May 27, 2026 133.83 136.19 132.59 133.69 132.81 5,032,595
May 26, 2026 135.25 136.32 133.68 133.73 132.85 6,409,619
May 22, 2026 131.57 134.52 131.12 134.36 133.48 5,973,641
May 21, 2026 130.01 131.34 129.42 130.50 129.65 4,920,772
May 20, 2026 131.36 131.95 129.49 130.69 129.83 5,571,182
May 19, 2026 129.50 132.34 128.34 130.50 129.65 5,008,997
May 18, 2026 130.15 131.05 129.22 129.67 128.82 5,182,249
May 15, 2026 132.27 132.81 129.09 129.58 128.73 6,641,026
May 14, 2026 133.77 134.65 131.81 132.06 131.19 4,533,202
May 13, 2026 133.55 135.07 131.88 133.05 132.18 6,666,706
May 12, 2026 135.00 137.50 132.72 134.94 134.06 6,034,938
May 11, 2026 131.01 134.86 130.98 133.52 132.65 5,384,970
May 8, 2026 130.00 133.34 129.00 131.33 130.47 10,250,367
May 7, 2026 136.50 136.50 133.76 134.06 133.18 8,901,045
May 6, 2026 133.38 136.75 133.19 136.30 135.41 6,351,160
May 5, 2026 132.84 133.98 131.89 133.48 132.60 6,152,431
May 4, 2026 130.44 133.10 130.00 132.69 131.82 5,880,732
May 1, 2026 130.00 132.36 129.01 131.65 130.79 5,517,169
Apr 30, 2026 127.96 132.21 127.96 130.84 129.98 6,660,240
Apr 29, 2026 128.90 129.96 128.00 128.84 128.00 5,048,293
Apr 28, 2026 130.33 130.47 128.34 129.26 128.41 5,940,261
Apr 27, 2026 128.80 130.33 127.64 127.75 126.91 8,170,310
Apr 24, 2026 131.54 132.32 129.28 130.40 129.54 5,966,098
Apr 23, 2026 134.02 134.68 132.78 133.64 132.76 3,870,913
Apr 22, 2026 133.69 134.07 131.34 132.90 132.03 6,695,769
Apr 21, 2026 136.18 136.34 132.22 133.29 132.42 6,070,570
Apr 20, 2026 138.06 138.54 135.48 135.87 134.98 3,871,215
Apr 17, 2026 138.95 139.76 136.69 137.64 136.74 7,345,882
Apr 16, 2026 138.61 140.26 137.75 138.55 137.64 3,432,531
Apr 15, 2026 140.96 140.96 138.06 139.77 138.85 3,790,526
Apr 14, 2026 138.26 141.40 137.60 140.45 139.53 6,473,797
Apr 13, 2026 137.99 139.55 137.02 139.03 138.12 5,101,886
Apr 10, 2026 142.38 142.38 138.45 138.99 138.08 4,418,834
Apr 9, 2026 140.12 142.97 139.96 142.09 141.16 4,167,442
Apr 8, 2026 140.10 141.57 138.47 141.54 140.61 4,967,271
Apr 7, 2026 139.00 139.39 137.15 138.80 137.89 5,439,157
Apr 6, 2026 139.24 140.71 138.85 140.13 139.21 3,922,123
Apr 2, 2026 139.61 141.34 138.64 139.71 138.79 4,925,897
Apr 1, 2026 139.69 141.49 138.82 140.30 139.38 5,286,456
Mar 31, 2026 137.18 140.35 137.17 139.37 138.46 7,878,992
Mar 30, 2026 134.57 136.63 133.89 136.34 135.45 6,148,332
Mar 27, 2026 136.85 137.47 134.10 134.25 133.37 5,647,185
Mar 26, 2026 138.39 138.94 136.66 136.88 135.98 4,285,651
Mar 25, 2026 139.76 140.41 137.92 138.26 137.35 5,053,337
Mar 24, 2026 136.80 138.37 136.47 138.11 137.21 6,725,458
Mar 23, 2026 139.68 139.80 136.44 137.34 136.44 7,364,174
Mar 20, 2026 140.43 141.00 136.49 137.21 136.31 15,521,887
Mar 19, 2026 141.41 142.09 140.12 141.11 140.19 7,310,679
Mar 18, 2026 143.16 143.79 139.23 141.29 140.36 7,079,634
Mar 17, 2026 146.52 146.71 143.27 144.40 143.45 3,887,912
Mar 16, 2026 144.23 146.13 142.68 145.21 144.26 3,697,501
Mar 13, 2026$0.82 dividend 146.85 148.22 144.20 144.99 144.04 4,375,701
Mar 12, 2026 145.11 146.95 143.89 145.21 143.45 7,006,787
Mar 11, 2026 147.11 149.30 145.81 146.00 144.23 5,552,156
Mar 10, 2026 147.73 149.38 146.84 148.56 146.76 5,098,461
Mar 9, 2026 143.50 146.92 143.49 146.63 144.85 5,210,502
Mar 6, 2026 143.56 144.65 142.77 143.93 142.18 4,921,313
Mar 5, 2026 146.32 146.75 143.34 145.14 143.38 6,944,156
Mar 4, 2026 148.92 148.92 146.10 148.22 146.42 6,925,216
Mar 3, 2026 148.13 148.84 145.52 147.83 146.03 6,741,675
Mar 2, 2026 147.87 150.77 147.80 150.03 148.21 7,183,285
Feb 27, 2026 143.56 150.00 143.37 148.95 147.14 11,195,856
Feb 26, 2026 145.92 146.36 143.09 143.77 142.03 7,987,607
Feb 25, 2026 147.35 149.11 146.39 147.12 145.33 6,209,090
Feb 24, 2026 149.72 150.08 147.05 147.64 145.85 8,334,027
Feb 23, 2026 148.93 152.46 148.38 149.83 148.01 5,994,769
Feb 20, 2026 150.58 153.25 150.09 151.40 149.56 6,986,978
Feb 19, 2026 152.34 152.81 150.33 151.12 149.28 7,357,970
Feb 18, 2026 156.01 156.01 152.37 152.74 150.89 5,190,851
Feb 17, 2026 155.04 155.75 153.31 155.27 153.38 5,885,152
Feb 13, 2026 151.89 156.95 151.46 154.98 153.10 6,861,934
Feb 12, 2026 153.42 155.73 150.82 151.81 149.97 9,891,223
Feb 11, 2026 148.90 157.29 147.38 155.80 153.91 11,433,950
Feb 10, 2026 151.47 151.87 147.07 147.23 145.44 10,774,639
Feb 9, 2026 151.84 153.00 150.18 151.68 149.84 7,431,212
Feb 6, 2026 149.69 153.13 148.71 152.50 150.65 8,510,037
Feb 5, 2026 146.50 150.50 145.87 149.37 147.56 9,143,045
Feb 4, 2026 144.14 146.73 143.50 146.23 144.46 7,440,114
Feb 3, 2026 142.16 145.94 142.03 143.28 141.54 6,840,192
Feb 2, 2026 141.05 143.80 140.01 142.89 141.16 6,898,220
Jan 30, 2026 139.08 142.20 138.65 141.95 140.23 9,460,236
Jan 29, 2026 139.75 140.51 138.23 139.55 137.86 7,148,282
Jan 28, 2026 140.41 140.87 138.69 139.72 138.02 7,317,700
Jan 27, 2026 137.54 141.71 137.54 140.97 139.26 10,615,822
Jan 26, 2026 135.88 138.03 133.69 137.78 136.11 10,012,523
Jan 23, 2026 131.26 136.30 131.00 135.93 134.28 13,180,915
Jan 22, 2026 129.13 133.10 129.00 131.14 129.55 8,550,528
Jan 21, 2026 123.73 129.39 122.68 129.11 127.54 7,285,253
Jan 20, 2026 123.80 126.24 122.28 124.14 122.63 9,152,643
Jan 16, 2026 123.80 125.12 122.10 124.91 123.39 10,639,074
Jan 15, 2026 124.31 124.57 120.94 121.26 119.79 6,659,785
Jan 14, 2026 121.38 124.16 121.38 124.07 122.56 4,659,420
Jan 13, 2026 122.59 123.81 120.22 121.76 120.28 5,803,884
Jan 12, 2026 120.58 124.48 119.63 122.60 121.11 7,397,037
Jan 9, 2026 120.34 122.76 119.33 121.10 119.63 6,629,526
Jan 8, 2026 124.08 125.11 119.93 120.67 119.20 6,717,804
Jan 7, 2026 122.34 124.71 122.16 124.35 122.84 6,175,370
Jan 6, 2026 118.22 121.99 118.22 121.36 119.89 6,038,195
Jan 5, 2026 120.77 121.00 116.88 118.30 116.86 7,039,107
Jan 2, 2026 122.49 122.59 121.19 121.60 120.12 4,555,506
Dec 31, 2025 123.23 123.60 122.38 122.74 121.25 3,150,182
Dec 30, 2025 124.56 125.00 122.95 123.18 121.69 3,256,025
Dec 29, 2025 124.82 125.27 124.20 124.91 123.39 3,061,395
Dec 26, 2025 125.52 125.77 124.19 124.70 123.19 2,073,829
Dec 24, 2025 125.71 126.25 125.12 125.67 124.14 1,606,328
Dec 23, 2025 124.17 127.41 124.00 125.19 123.67 5,712,815
Dec 22, 2025 124.08 124.90 122.84 124.16 122.65 6,751,351
Dec 19, 2025 121.19 126.27 121.00 124.29 122.78 24,394,985
Dec 18, 2025 121.24 122.29 120.93 121.47 120.00 5,795,444
Dec 17, 2025 119.27 122.07 118.58 121.36 119.89 7,959,025
Dec 16, 2025 120.53 121.64 118.17 118.78 117.34 6,417,477
Dec 15, 2025$0.79 dividend 122.00 122.98 119.39 119.78 118.33 7,805,068
Dec 12, 2025 122.86 123.62 119.53 120.40 118.16 6,767,829
Dec 11, 2025 122.25 123.74 121.00 123.21 120.92 4,892,293
Dec 10, 2025 119.48 121.41 118.78 121.34 119.08 8,530,529
Dec 9, 2025 121.07 122.25 119.02 119.36 117.14 7,256,046
Dec 8, 2025 120.98 122.37 120.54 121.19 118.93 8,870,661
Dec 5, 2025 122.29 122.53 120.38 121.22 118.96 10,417,014
Dec 4, 2025 124.81 124.96 122.40 122.62 120.34 5,234,244
Dec 3, 2025 124.21 125.60 123.88 125.00 122.67 5,306,324
Dec 2, 2025 124.40 125.08 123.39 123.91 121.60 5,109,934
Dec 1, 2025 125.89 126.23 123.62 124.33 122.02 4,960,221
Nov 28, 2025 127.10 127.80 124.90 125.84 123.50 3,063,631
Nov 26, 2025 126.94 128.16 126.36 127.51 125.14 5,825,580
Nov 25, 2025 124.78 127.61 124.70 127.12 124.75 7,589,832
Nov 24, 2025 126.96 128.25 124.49 125.27 122.94 9,553,634
Nov 21, 2025 125.34 127.98 125.07 126.64 124.28 10,379,347
Nov 20, 2025 128.34 128.70 124.54 124.99 122.66 9,924,201
Nov 19, 2025 127.09 128.10 125.86 128.07 125.69 6,881,858
Nov 18, 2025 124.54 127.36 123.32 127.18 124.81 8,179,017
Nov 17, 2025 125.23 126.53 123.91 124.09 121.78 5,758,104
Nov 14, 2025 124.81 125.64 122.50 125.02 122.69 6,599,516
Nov 13, 2025 123.75 127.68 123.60 125.20 122.87 9,253,823
Nov 12, 2025 122.40 124.86 121.80 123.40 121.10 6,004,794
Nov 11, 2025 118.61 122.75 118.58 122.56 120.28 6,281,101
Nov 10, 2025 119.39 119.85 117.13 118.15 115.95 7,566,149
Nov 7, 2025 123.89 124.00 117.54 118.84 116.63 9,065,913
Nov 6, 2025 121.93 124.10 121.72 123.40 121.10 6,087,496
Nov 5, 2025 122.20 123.73 121.71 122.58 120.30 6,417,503
Nov 4, 2025 123.15 123.57 119.24 123.00 120.71 8,467,179
Nov 3, 2025 119.82 122.31 119.10 122.05 119.78 8,294,114
Oct 31, 2025 116.06 121.91 114.02 119.79 117.56 10,030,185
Oct 30, 2025 118.80 120.52 117.52 118.44 116.23 8,349,594
Oct 29, 2025 117.12 118.96 116.70 118.50 116.29 6,032,321
Oct 28, 2025 119.77 120.28 117.79 117.88 115.69 4,723,541
Oct 27, 2025 121.49 121.58 119.50 120.47 118.23 4,752,728
Oct 24, 2025 120.42 121.14 118.70 120.94 118.69 5,438,759
Oct 23, 2025 121.75 121.88 119.45 120.74 118.49 4,635,345
Oct 22, 2025 124.24 124.45 121.30 121.46 119.20 5,436,308
Oct 21, 2025 123.27 124.61 121.92 124.08 121.77 5,559,031
Oct 20, 2025 122.59 123.99 122.20 123.11 120.82 8,149,673
Oct 17, 2025 119.64 124.11 119.09 122.81 120.52 15,845,861
Oct 16, 2025 117.98 121.57 117.34 117.85 115.66 6,742,969
Oct 15, 2025 118.08 119.07 117.07 118.30 116.10 4,552,240
Oct 14, 2025 117.52 119.33 116.62 118.48 116.28 6,311,218
Oct 13, 2025 116.34 118.78 115.80 118.21 116.01 5,124,618
Oct 10, 2025 117.65 119.33 116.50 117.18 115.00 7,896,618
Oct 9, 2025 118.75 118.86 116.51 116.74 114.57 5,019,053
Oct 8, 2025 117.11 118.35 115.75 118.25 116.05 6,532,171
Oct 7, 2025 113.60 116.91 112.82 116.78 114.61 8,712,575
Oct 6, 2025 115.67 117.00 112.41 113.58 111.47 9,090,734
Oct 3, 2025 110.74 113.59 109.66 112.69 110.59 8,089,076
Oct 2, 2025 110.20 111.70 108.46 110.56 108.50 10,135,000
Oct 1, 2025 112.00 113.07 110.20 111.15 109.08 13,650,010
Sep 30, 2025 113.03 114.86 110.92 111.00 108.93 10,301,730
Sep 29, 2025 112.55 112.70 110.82 112.62 110.52 7,122,222
Sep 26, 2025 111.35 112.23 110.70 112.10 110.01 5,074,303
Sep 25, 2025 114.52 115.25 110.81 110.99 108.92 8,355,787
Sep 24, 2025 114.30 114.57 111.96 113.67 111.55 5,222,766
Sep 23, 2025 111.88 115.57 111.75 114.40 112.27 7,281,771

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Gilead Sciences Inc Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at GILD, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation